Abstract：Objective To investigate the most common sites and the impact of survival prognosis for patients in the extrahepatic metastasis of liver cancer.Methods One hundred and thirty-two cases confirmed with HCC extrahepatic metastasis by PET/CT examination were collected in our department. These cases were retrospectively analyzed, univariate and multivariate survival analysis were conducted.Results The most common sites of HCC extrahepatic metastasis were lymph nodes (54.5%,72/132), bone (24.2%, 32/132) and lung (21.2%, 28/132), the univariate and multivariate survival analysis prompted to lymph node metastasis had a significant effect on survival prognosis (all P values＜0.05), while other transfer locus and physiological indices had no significant effects (all P values＞0.05).Conclusions Lymph node metastasis in HCC extrahepatic metastasis is the most common and can significantly affect patients survival prognosis. Early diagnosis and treatment of lymph node metastasis in patients will be able to improve the quality of survival and prolong the survival time.
李果，吴黎雳，宦宏波，马宽生，李晓武，别平，夏锋. 肝细胞癌肝外转移对患者生存预后的影响[J]. 中华解剖与临床杂志, 2014, 19(4): 307-309.
Guo, Wu Lili, Huan Hongbo, Ma Kuansheng, Li Xiaowu, Bie Ping, Xia Feng. Extrahepatic metastasis markedly impact on the survival in hepatocellular carcinoma patients. Chinese Journal of Anatomy and Clinics, 2014, 19(4): 307-309.
Arii S, Yamaoka Y, Futagawa S, et al. Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: A retrospective and nationwide survey in Japan[J]. Hepatology, 2000, 32(6): 1224-1229.
[3]
Llovet JM, Real MI, Montana X, et al.Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: A randomised controlled trial[J]. Lancet, 2002, 359(9319): 1734-1739.
[4]
Shiina S, Teratani T, Obi S, et al. A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma[J]. Gastroenterology, 2005, 129(1): 122-130.
[5]
Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis[J]. N Engl J Med, 1996, 334(11): 693-699.
[6]
Kanda M, Tateishi R, Yoshida H, et al. Extrahepatic metastasis of hepatocellular carcinoma: Incidence and risk factors[J]. Liver Int, 2008, 28(9): 1256-1263.
[7]
Katyal S, Oliver Iii JH, Peterson MS, et al., Extrahepatic metastases of hepatocellular carcinoma[J]. Radiology, 2000, 216(3): 698-703.
[8]
Rigo P, Paulus P, Kaschten B, et al. Oncological applications of positron emission tomography with fluorlne-18 fluorodeoxyglucose[J]. Euro J Nucl Med, 1996, 23(12): 1641-1674.
[9]
Iglehart JK, The new era of medical imaging - Progress and pitfalls[J]. N Engl J Med, 2006, 354(26): 2822-2828.
[10]
Yoon KT, Kim JK, Kim do Y, et al. Role of 18F-fluorodeoxyglucose positron emission tomography in detecting extrahepatic metastasis in pretreatment staging of hepatocellular carcinoma[J]. Oncology, 2007, 72(Suppl 1): 104-110.
[11]
Lee CW, Chan KM, Lee CF, et al. Hepatic resection for hepatocellular carcinoma with lymph node metastasis: clinicopathological analysis and survival outcome[J]. Asian J Surg, 2011, 34(2): 53-62.
2014, Vol. 19 
